vs
Nutex Health, Inc.（NUTX）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
ROGERS CORP的季度营收约是Nutex Health, Inc.的1.3倍（$200.5M vs $151.7M），Nutex Health, Inc.净利率更高（7.8% vs 2.2%，领先5.6%），ROGERS CORP同比增速更快（5.2% vs -41.1%），Nutex Health, Inc.自由现金流更多（$69.0M vs $1.1M），过去两年Nutex Health, Inc.的营收复合增速更高（50.0% vs -3.3%）
Nutex Health是一家总部位于美国得克萨斯州休斯敦的营利性医疗企业，核心业务为运营各类医疗机构，是美国本土医疗领域的专业运营机构，致力于为当地市场提供相关医疗服务与场地运营支持。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
NUTX vs ROG — 直观对比
营收规模更大
ROG
是对方的1.3倍
$151.7M
营收增速更快
ROG
高出46.4%
-41.1%
净利率更高
NUTX
高出5.6%
2.2%
自由现金流更多
NUTX
多$67.9M
$1.1M
两年增速更快
NUTX
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $151.7M | $200.5M |
| 净利润 | $11.8M | $4.5M |
| 毛利率 | 30.4% | 32.2% |
| 营业利润率 | 20.4% | — |
| 净利率 | 7.8% | 2.2% |
| 营收同比 | -41.1% | 5.2% |
| 净利润同比 | -80.8% | 421.4% |
| 每股收益（稀释后） | $2.34 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NUTXROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $151.7M | $201.5M | ||
| Q3 25 | $267.8M | $216.0M | ||
| Q2 25 | $244.0M | $202.8M | ||
| Q1 25 | $211.8M | $190.5M | ||
| Q4 24 | $257.6M | $192.2M | ||
| Q3 24 | $78.8M | $210.3M | ||
| Q2 24 | $76.1M | $214.2M |
净利润NUTXROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $11.8M | $4.6M | ||
| Q3 25 | $55.4M | $8.6M | ||
| Q2 25 | $-17.7M | $-73.6M | ||
| Q1 25 | $21.2M | $-1.4M | ||
| Q4 24 | $61.6M | $-500.0K | ||
| Q3 24 | $-8.8M | $10.7M | ||
| Q2 24 | $-364.0K | $8.1M |
毛利率NUTXROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | 30.4% | 31.5% | ||
| Q3 25 | 57.8% | 33.5% | ||
| Q2 25 | 51.2% | 31.6% | ||
| Q1 25 | 55.9% | 29.9% | ||
| Q4 24 | 55.0% | 32.1% | ||
| Q3 24 | 27.8% | 35.2% | ||
| Q2 24 | 29.7% | 34.1% |
营业利润率NUTXROG
| Q1 26 | — | — | ||
| Q4 25 | 20.4% | 3.5% | ||
| Q3 25 | 48.7% | 7.3% | ||
| Q2 25 | 13.8% | -33.3% | ||
| Q1 25 | 38.1% | -0.2% | ||
| Q4 24 | 44.4% | -6.6% | ||
| Q3 24 | 12.3% | 6.9% | ||
| Q2 24 | 7.0% | 5.3% |
净利率NUTXROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | 7.8% | 2.3% | ||
| Q3 25 | 20.7% | 4.0% | ||
| Q2 25 | -7.3% | -36.3% | ||
| Q1 25 | 10.0% | -0.7% | ||
| Q4 24 | 23.9% | -0.3% | ||
| Q3 24 | -11.2% | 5.1% | ||
| Q2 24 | -0.5% | 3.8% |
每股收益（稀释后）NUTXROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $2.34 | $0.20 | ||
| Q3 25 | $7.76 | $0.48 | ||
| Q2 25 | $-2.95 | $-4.00 | ||
| Q1 25 | $3.33 | $-0.08 | ||
| Q4 24 | $11.56 | $-0.04 | ||
| Q3 24 | $-1.72 | $0.58 | ||
| Q2 24 | $-0.07 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $185.6M | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $329.4M | $1.2B |
| 总资产 | $918.5M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NUTXROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $185.6M | $197.0M | ||
| Q3 25 | $166.0M | $167.8M | ||
| Q2 25 | $96.7M | $157.2M | ||
| Q1 25 | $84.7M | $175.6M | ||
| Q4 24 | $40.6M | $159.8M | ||
| Q3 24 | $46.9M | $146.4M | ||
| Q2 24 | $40.8M | $119.9M |
股东权益NUTXROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $329.4M | $1.2B | ||
| Q3 25 | $317.2M | $1.2B | ||
| Q2 25 | $235.3M | $1.2B | ||
| Q1 25 | $176.9M | $1.3B | ||
| Q4 24 | $132.4M | $1.3B | ||
| Q3 24 | $60.4M | $1.3B | ||
| Q2 24 | $62.7M | $1.3B |
总资产NUTXROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $918.5M | $1.4B | ||
| Q3 25 | $964.5M | $1.4B | ||
| Q2 25 | $841.0M | $1.5B | ||
| Q1 25 | $761.9M | $1.5B | ||
| Q4 24 | $655.3M | $1.5B | ||
| Q3 24 | $438.5M | $1.5B | ||
| Q2 24 | $422.4M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $70.4M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $69.0M | $1.1M |
| 自由现金流率自由现金流/营收 | 45.5% | 0.5% |
| 资本支出强度资本支出/营收 | 0.9% | 2.3% |
| 现金转化率经营现金流/净利润 | 5.95× | 1.29× |
| 过去12个月自由现金流最近4个季度 | $245.6M | $70.1M |
8季度趋势，按日历期对齐
经营现金流NUTXROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $70.4M | $46.9M | ||
| Q3 25 | $99.5M | $28.9M | ||
| Q2 25 | $27.3M | $13.7M | ||
| Q1 25 | $51.0M | $11.7M | ||
| Q4 24 | $54.0K | $33.7M | ||
| Q3 24 | $6.8M | $42.4M | ||
| Q2 24 | $13.3M | $22.9M |
自由现金流NUTXROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $69.0M | $42.2M | ||
| Q3 25 | $99.2M | $21.2M | ||
| Q2 25 | $26.5M | $5.6M | ||
| Q1 25 | $50.9M | $2.1M | ||
| Q4 24 | $-341.0K | $18.3M | ||
| Q3 24 | $6.2M | $25.2M | ||
| Q2 24 | $12.7M | $8.8M |
自由现金流率NUTXROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | 45.5% | 20.9% | ||
| Q3 25 | 37.0% | 9.8% | ||
| Q2 25 | 10.9% | 2.8% | ||
| Q1 25 | 24.0% | 1.1% | ||
| Q4 24 | -0.1% | 9.5% | ||
| Q3 24 | 7.8% | 12.0% | ||
| Q2 24 | 16.7% | 4.1% |
资本支出强度NUTXROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 0.9% | 2.3% | ||
| Q3 25 | 0.1% | 3.6% | ||
| Q2 25 | 0.3% | 4.0% | ||
| Q1 25 | 0.0% | 5.0% | ||
| Q4 24 | 0.2% | 8.0% | ||
| Q3 24 | 0.8% | 8.2% | ||
| Q2 24 | 0.7% | 6.6% |
现金转化率NUTXROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | 5.95× | 10.20× | ||
| Q3 25 | 1.80× | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
ROG
暂无分部数据
